Evidence map›Paper›PMID 24144440›Full record

Trial reportSchizophrenia research2013

Effect of parental age on treatment response in adolescents with schizophrenia.

Mark Opler, Dolores Malaspina, Srihari Gopal, Isaac Nuamah, Adam J Savitz, Jaskaran Singh, David Hough

Registry-linked trialOpen access · greenAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Schizophrenia research, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT00518323 (A Randomized, Multicenter, Double-Blind, Weight-Based, Fixed-Dose, Parallel-Group, Placebo-Controlled Study of the Efficacy and Safety of Extended Release Paliperidone for the Treatment of Schizophrenia in Adolescent Subjects, 12 to 17 Years of Age), which is not on this map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.8field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00518323 phase3completednot on this map

A Randomized, Multicenter, Double-Blind, Weight-Based, Fixed-Dose, Parallel-Group, Placebo-Controlled Study of the Efficacy and Safety of Extended Release Paliperidone for the Treatment of Schizophrenia in Adolescent Subjects, 12 to 17 Years of Age

TypeinterventionalSponsorJohnson & Johnson Pharmaceutical Research & Development, L.L.C.Ran2007 to 2009Enrolled201ConditionsSchizophreniaArmsPaliperidone ER, Placebo
3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Review
  3. Paternal age effect: Replication in schizophrenia with intriguing dissociation between bipolar with and without psychosis.American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics · 2016
    Article
  4. The Effect of Paternal Age on Relapse in First-Episode Schizophrenia.Canadian journal of psychiatry. Revue canadienne de psychiatrie · 2015
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Mark OplerNYU School of Medicine, Dept. of Psychiatry, InSPIRES, NY, USA. Electronic address: mark.opler@ProPhase.com.
Dolores Malaspina
Srihari Gopal
Isaac Nuamah
Adam J Savitz
Jaskaran Singh
David Hough
Janssen (United States) · USInspire Institute · US

Funding

Jerusalem Perinatal Cohort Schizophrenia Study IIR01MH059114 · NIMH · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI MALASPINA, DOLORES · 1999 to 2011
$7.3M
Paternal Age Related Schizophrenia as a Discrete DisorderRC1MH088843 · NIMH · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI MALASPINA, DOLORES · 2009 to 2010
$979k
Paternal Germ Line Effects and the Risk of Schizophrenia in OffspringK01MH080114 · NIMH · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI OPLER, MARK G · 2008 to 2012
$782k
NIMH NIH HHS K01 MH080114NIMH NIH HHS R01 MH059114NIMH NIH HHS R01 MH59114-09NIMH NIH HHS RC1 MH088843NIMH NIH HHS RC1 MH088843-01
6 · The paper itself

Abstract

backgroundAdvanced paternal age (APA) is associated with increased risk for schizophrenia, but its effect on treatment response has not been longitudinally studied.

methodsAssociation of parental ages at the time of the child's birth with age of onset, initial symptom severity and treatment response (to placebo and three different weight-based doses of paliperidone ER) in adolescents with schizophrenia was assessed in a post-hoc analysis using data from a 6-week double-blind study, the primary results of which are published (NCT00518323).

resultsThe mean (SD) paternal age was 29.2 (6.2) years, range (16-50) and maternal age was 26.8 (5.7) years, range (17-42) at childbirth for the 201 adolescents (ages 12-17 years) included in the analysis. While parental ages were uncorrelated with age of onset or initial symptom severity, both maternal and paternal ages showed significant effects on treatment response (p<0.03) of all paliperidone ER arms versus placebo. Paternal age was significantly correlated to improvement in positive symptoms and maternal age significantly related to negative symptoms, although only paternal age remained significantly associated with the treatment response in analyses that included both parents' ages.

conclusionsAPA was associated with greater treatment response to both paliperidone ER and placebo, but not to age of onset or initial symptom severity in adolescents with schizophrenia. The results support the contention that APA-related schizophrenia has distinct underpinnings from other cases. Further studies are required to explore the role of genetic and environmental factors, and their interactions, in treatment response in this complex disorder.

Indexed as

Paternal AgeAdolescentAdultAntipsychotic AgentsChildDouble-Blind MethodFemaleHumansIsoxazolesLongitudinal StudiesMaleMiddle AgedPaliperidone PalmitatePyrimidinesSchizophreniaSchizophrenic PsychologyAntipsychotic AgentsIsoxazolesPaliperidone PalmitatePyrimidinesAdolescentsHeterogeneityPaternal agePlaceboSchizophreniaTreatment response

Identifiers

PMID24144440
PMCPMC4208878
OpenAlexW2139668142

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.